Genky DrugStores Co., Ltd. (9267.T)
JPY 3190.0
(1.11%)
JPY 3190.0
(1.11%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 184.86 Billion | 169.05 Billion | 154.63 Billion | 142.37 Billion | 123.6 Billion | 103.89 Billion |
| Cost of Revenue | 147.23 Billion | 134.5 Billion | 123.68 Billion | 112.08 Billion | 96.89 Billion | 79.47 Billion |
| Gross Profit | 37.62 Billion | 34.55 Billion | 30.95 Billion | 30.28 Billion | 26.71 Billion | 24.41 Billion |
| Operating Expenses | 28.6 Billion | 27.84 Billion | 25.27 Billion | 23.99 Billion | 22.37 Billion | 20.37 Billion |
| Selling, General and Administrative Expenses | 28.6 Billion | 23.19 Billion | 21 Billion | 19.91 Billion | 22.37 Billion | 20.37 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 431 Million | 436.81 Million | 352.31 Million | 275.88 Million | 293.97 Million |
| Cost and Expenses | 175.84 Billion | 162.34 Billion | 148.96 Billion | 136.08 Billion | 119.26 Billion | 99.85 Billion |
| Operating Income | 9.01 Billion | 6.7 Billion | 5.67 Billion | 6.29 Billion | 4.34 Billion | 4.04 Billion |
| Interest Expense | 103 Million | 70 Million | 59.09 Million | 55.51 Million | 61.72 Million | 49.39 Million |
| Income Tax Expense | 2.47 Billion | 1.93 Billion | 1.66 Billion | 1.83 Billion | 1.27 Billion | 1.18 Billion |
| Earnings before Tax | 8.8 Billion | 6.7 Billion | 6.08 Billion | 6.66 Billion | 4.03 Billion | 3.88 Billion |
| Net Income | 6.32 Billion | 4.76 Billion | 4.42 Billion | 4.83 Billion | 2.75 Billion | 2.69 Billion |
| Earnings Per Share Basic | 208.18 | 156.89 | 145.59 | 159.15 | 90.76 | 87.35 |
| Earnings Per Share Diluted | 207.91 | 156.79 | 145.44 | 159.01 | 90.76 | 87.35 |
| Weighted Average Shares Outstanding | 30.37 Million | 30.38 Million | 30.39 Million | 30.38 Million | 30.35 Million | 30.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.41 Million | 30.39 Million | 30.39 Million | 30.38 Million | 30.35 Million | 30.88 Million |
| Gross Margin | 0.20 | 0.20 | 0.20 | 0.21 | 0.22 | 0.24 |
| EBIT Margin | 0.08 | 0.07 | 0.07 | 0.08 | 0.07 | 0.07 |
| Profit Margin | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 |
| EBITDA | 14.47 Billion | 11.72 Billion | 10.73 Billion | 10.77 Billion | 7.85 Billion | 7.25 Billion |
| Earnings Before Tax Margin | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 50.05 Billion | 48.27 Billion | 184.86 Billion | 44.62 Billion | 45.09 Billion | 46.87 Billion |
| Cost of Revenue | 39.94 Billion | 38.29 Billion | 147.23 Billion | 35.76 Billion | 35.66 Billion | 37.52 Billion |
| Gross Profit | 10.1 Billion | 9.98 Billion | 37.62 Billion | 8.85 Billion | 9.43 Billion | 9.34 Billion |
| Operating Expenses | 7.83 Billion | 7.46 Billion | 28.6 Billion | 6.74 Billion | 7.06 Billion | 7.33 Billion |
| Selling, General and Administrative Expenses | 7.83 Billion | 7.46 Billion | - | 6.74 Billion | 7.06 Billion | 7.33 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 92 Million | 349 Million | 108 Million | 63 Million | 86 Million |
| Cost and Expenses | 47.77 Billion | 45.75 Billion | 175.84 Billion | 42.51 Billion | 42.72 Billion | 44.85 Billion |
| Operating Income | 2.27 Billion | 2.52 Billion | 9.01 Billion | 2.1 Billion | 2.37 Billion | 2.01 Billion |
| Interest Expense | 74 Million | 34 Million | 103 Million | 26 Million | 28 Million | 15 Million |
| Income Tax Expense | 715 Million | 474 Million | 2.47 Billion | 651 Million | 709 Million | 644 Million |
| Earnings before Tax | 2.3 Billion | 2.34 Billion | 8.8 Billion | 2.01 Billion | 2.35 Billion | 2.08 Billion |
| Net Income | 1.58 Billion | 1.86 Billion | 6.32 Billion | 1.36 Billion | 1.64 Billion | 1.44 Billion |
| Earnings Per Share Basic | 52.13 | 61.49 | - | 45.07 | 54.09 | 47.54 |
| Earnings Per Share Diluted | 52.04 | 61.41 | - | 44.97 | 54.03 | 47.52 |
| Weighted Average Shares Outstanding | 30.38 Million | 30.37 Million | 30.37 Million | 30.44 Million | 30.4 Million | 30.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.43 Million | 30.41 Million | 30.41 Million | 30.42 Million | 30.42 Million | 30.38 Million |
| Gross Margin | 0.20 | 0.21 | 0.20 | 0.20 | 0.21 | 0.20 |
| EBIT Margin | 0.08 | 0.08 | - | 0.05 | 0.05 | 0.04 |
| Profit Margin | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 |
| EBITDA | 3.8 Billion | 4.01 Billion | - | 2.1 Billion | 2.43 Billion | 2.1 Billion |
| Earnings Before Tax Margin | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
BPMUF
0N0B
ALNLF
DR
0804
AVB